Ortho Evra Related Clinical Trials
To Compare SH T00658ID to Ortho Tri-Cyclen Lo (US/Canada) [Recruiting]
Drug Interaction - Oral Contraceptive [Completed]
A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA® (a Transdermal Contraceptive Patch) [Completed]
Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women [Active, not recruiting]
Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity [Recruiting]
Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females [Completed]
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks. [Active, not recruiting]
Relative Risks for Non-Fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-Containing Oral Contraceptives. [Completed]
A Comparative Pharmacokinetic Study of ORTHO EVRA® (a Transdermal Contraceptive Patch) and CILEST® (an Oral Contraceptive) in Healthy Female Volunteers [Completed]
Continuous Use of the Contraceptive Patch and the Personal Economic Impact. [Suspended]
Side Effect Profiles of Brand Name vs.Generic Oral Contraceptives [Recruiting]
An Open-Label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method [Completed]
An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen [Completed]
Bioequivalence Study of Patches With Different Release Profiles [Completed]
Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions [Completed]
Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions [Completed]
Comparison of Continuation Rates [Active, not recruiting]
Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Using Oral Contraceptives [Active, not recruiting]
Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg [Completed]
Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg [Completed]
Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg [Completed]
A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole [Completed]
An Open-Label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-Dissolving Tablet Formulation of Risperdone [Completed]
A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery. [Completed]
An Effectiveness and Safety Study of CONCERTA* Vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children [Active, not recruiting]
CONCERTA® (OROS® Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults [Completed]
A Randomized, Open-Label Trial of Long-Acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder [Completed]
CONCERTA® (Methylphenidate Hydrochloride) as Add-on Therapy in the Treatment of Adult Major Depressive Disorder. [Completed]
An Open-Label Randomized Trial Comparing Long-Acting Injectable Risperidone With Oral Antipsychotic Medication in the Treatment of Early Psychosis [Active, not recruiting]
An Open-Label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With Triptans
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)
A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery
A Safety and Efficacy Study for Epoetin Alfa in Pre-Dialysis Subjects.
Impact of Erythropoietin Treatment Versus Placebo on Quality-of-Life in Patients With Advanced Prostate Cancer.
Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-Esophageal Reflux Disease (GERD) Patients With Night-Time Heartburn Symptoms. [Completed]
A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn [Completed]
Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain [Completed]
Birth Control Pill vs Birth Control Patch Study [Completed]
Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine [Completed]
A 1-Year Study in Adolescents to Assess the Long-Term Safety of Almotriptan Malate When Treating Their Migraine Headaches [Completed]
A Study of 3 Dosage Strengths of Aalmotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents [Completed]
A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache [Completed]
A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA® (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST® (an Oral Contraceptive) [Completed]
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia [Completed]
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy [Completed]
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy [Completed]
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy [Completed]
The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic [Completed]
The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT [Completed]
The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study) [Completed]
Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy [Completed]
The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain [Completed]
Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache [Completed]
Topiramate Versus Placebo as Add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting [Completed]
A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children [Completed]
the Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease. [Completed]
A Phase III Clinical Trial of PROCRIT® (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer [Terminated]
A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT® (Epoetin Alfa) [Terminated]
A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy. [Terminated]
RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia [Terminated]
Dosing and Outcomes Study of Erythropoietic Stimulating Therapies (D.O.S.E. Registry) [Enrolling by invitation]
Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis [Withdrawn]
A Study to Evaluate the Effect of Weekly PROCRIT® (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy [Completed]
A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT) [Completed]
NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection [Completed]
Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia [Completed]
An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT® (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II) [Completed]
A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV) [Completed]
A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease. [Terminated]
Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia [Withdrawn]
A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor [Active, not recruiting]
Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-Epileptic Drugs (AEDs) in Patients With Epilepsy. [Suspended]
Safety of Estrogens in Lupus: Birth Control Pills [Completed]
Paliperidone ER Study of Economic, Functional, and Clinical Outcomes. [Recruiting]
Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease [Recruiting]
Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone [Not yet recruiting]
Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis [Recruiting]
A Complicated Skin and Soft-Tissue Infection Patient Registry [Recruiting]
Effectiveness of the Diaphragm for HIV Prevention [No longer recruiting]
An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen [Completed]
The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa [Completed]
A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients [Recruiting]
A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Patients With a History of Being Poorly Compliant With Taking Their Medication [Recruiting]
An Efficacy and Safety Study for Bortezomib in Patients Previously Treated for Multiple Myeloma With Limited Kidney Function. [Not yet recruiting]
Oral Contraceptives in the Metabolic Syndrome [Recruiting]
An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-Acquired) Pneumonia [Recruiting]
Acceptablity of the NuvaRing Among Students [Recruiting]
A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy [No longer recruiting]
A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy [No longer recruiting]
Twins Study of Gene Therapy for HIV Infection [Completed]
Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer [Completed]
Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With MM [Recruiting]
Acceptability of NuvaRing to College Women [Recruiting]
Pharmacokinetics and Safety of Transdermal Megestrol Acetate [Recruiting]
Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin [Terminated]
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [Recruiting]
Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer [No longer recruiting]
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome [Completed]
Epoetin Alfa in Treating Cancer-Related Anemia in Patients With Non-Myeloid Cancer Who Are Not Currently Receiving Chemotherapy or Radiation Therapy [No longer recruiting]
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [Recruiting]
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy [No longer recruiting]
|
